Search

everythinglearnresearchcommunity

for

Search:↓

Blocking casein kinase 1 in skin cells can help melanocyte precursors move better, potentially helping with conditions like vitiligo or gray hair.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

High ornithine decarboxylase levels may lead to hair loss and cancer by increasing CK2 activity in the nucleus.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Polyamines are crucial for skin tumor development, and inhibiting them can prevent tumors.

Dkk4 protein helps control how hair grows and its arrangement.

A new protein, mK6irs, is found in specific hair layers and may help understand hair growth and diseases.

K6hf is a unique protein found only in a specific layer of hair follicles.

p21waf1/cip1 and p27kip1 help in hair follicle differentiation in rats.

Decreasing MIG6 can increase the movement and invasiveness of MEK-inhibited mutant NRAS melanoma, particularly when stimulated by EGF.

ODC overexpression in hair cells increases tumor growth by reducing Notch signaling.

Deleting the MAD2L1 gene is tolerated in certain mouse cancer models.

Topical IKKα inhibitors may help prevent CCS tumours.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.

Chromosomal microarray analysis is important for diagnosing rare genetic variations and guiding treatment.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

PDCD4 is important for controlling skin cell growth and healing.

A new one-step test can quickly identify skin cancer during surgery.

Cancer-associated fibroblasts promote tumor growth in skin cancer.

Mice with extra PKCδ resist chemical-induced skin cancer but not UV-induced.

Overexpressing PKCepsilon in mice reduces papillomas but increases carcinomas.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

New RIPK4 gene mutations were found to cause a type of skin and limb birth defect.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Increasing PDCD4 protein may help prevent or treat some skin cancers.

Suppressing eIF4E can prevent hair loss from chemotherapy.

The document concludes that the development of certain tumors is influenced by genetic background and that a specific gene modification can lead to tumor regression and reduced growth.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

A chromosomal change may cause ectodermal dysplasia and developmental issues in a child.